Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    29-August-2000      
Issue 138 Next Update - 14:00 UTC 08:00 EST    30-August-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya



















Proceed To Article In Today's Vidyya
Government Report Cover
Hemophilia patients who contracted AIDS in the 80s will begin to see compensation soon.


Proceed To Article HHS Begins Notifying Ricky Ray Hemophilia Relief Fund Recipients Of Payments
HHS Secretary Donna E. Shalala announced today that the Department of Health and Human Services began notifying the first eligible families that will receive payments from the Ricky Ray Hemophilia Relief Fund. More...

Proceed To Article Additional Prescription Dispensing Errors Involving Lamictal Tablets And Lamisil Tablets Reported
Medication dispensing errors are a serious threat to quality health care and necessitate the combined efforts of prescribers, dispensers, manufacturers and patients to minimize their occurrence. Glaxo Wellcome Inc. has received reports of dispensing errors involving Lamictal ® (lamotrigine) Tablets and other prescription drugs; most of these errors have been with the prescription medication Lamisil ® (terbinafine hydrochloride) Tablets, some of which have resulted in serious adverse events. More...

Proceed To Article Complete Prescribing Information For Lamictal® (Lamotrigine)
Lamictal is an antiepileptic drug marketed as 25-mg (white), 100-mg (peach), 150-mg (cream), and 200-mg (blue), shield-shaped tablets bearing "Lamictal " and the numeric representation of the strength (e.g., "Lamictal ®150"). Lamictal Chewable Dispersible Tablets are 5mg and 25mg white tablets engraved with "GX CL2" and "GX CL5," respectively. More...

Proceed To Article AMA Heads To Oklahoma And Tennessee To Mobilize Support For Patients' Bill Of Rights
With a Senate vote on a patients' bill of rights expected in early September, American Medical Association leaders this week head to Oklahoma and Tennessee to mobilize grassroots support to pass a strong patients' bill of rights. More...

Proceed To Article

Beta Blocking Agent Demonstrates Survival Benefit In Patients With Advanced Heart Failure
Landmark study results reported by researchers showed that the beta blocking agent Coreg® (carvedilol) decreased mortality rates by 35 percent in patients with the most advanced stage of heart failure who were already taking standard therapy. Coreg is the first beta blocking agent to show a significant survival benefit in this patient population. These results were presented today at the European Society of Cardiologists (ESC) 22nd Annual Congress in Amsterdam. More...


Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.